HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Diisopropylethylamine → (8aS)-N-(4-Chloro-2-cyclopropylpyridin-3-yl)-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]hexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxamide

HRID 1260477
Print

Reaction equation

HRID 1260477 reaction equation
[CH3:1][CH2:2][N:3](C(C)C)C(C)C.Cl[C:11]([Cl:21])(OC(=O)OC(Cl)(Cl)Cl)Cl.ClC1[C:28](Cl)=[CH:27][CH:26]=[CH:25][C:24]=1[NH:30][C:31]([N:33]1[CH2:38][CH2:37][N:36]2[C:39](=[O:52])[N:40]([C@H:43]3[CH2:45][C@@H:44]3[C:46]3[CH:51]=[CH:50][CH:49]=[CH:48][CH:47]=3)[C:41](=[O:42])[C@@H:35]2[CH2:34]1)=[O:32].Cl.C1([C@H]2C[C@@H]2N2C(=O)[C@@H]3CNCCN3C2=O)C=CC=CC=1>C(Cl)Cl.ClCCCl>[Cl:21][C:11]1[CH:1]=[CH:2][N:3]=[C:25]([CH:26]2[CH2:28][CH2:27]2)[C:24]=1[NH:30][C:31]([N:33]1[CH2:38][CH2:37][N:36]2[C:39](=[O:52])[N:40]([C@H:43]3[CH2:45][C@@H:44]3[C:46]3[CH:51]=[CH:50][CH:49]=[CH:48][CH:47]=3)[C:41](=[O:42])[C@@H:35]2[CH2:34]1)=[O:32]
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

7

Reactant 4

HCID 81531Diisopropylethylamine2×HCID 94429TriphosgeneHCID 56676510(8aS)-N-(2,3-dichlorophenyl)-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]-5,6,8,8a-tetrahydroimidazo[1,5-a]pyrazine-7-carboxamideHCID 67300061(8aS)-2-[(1S,2R)-2-Phenylcyclopropyl]tetrahydroimidazo[1,5-a]pyrazine-1,3(2H,5H)-dione HCl salt

Product 1

HCID 67300227
(8aS)-N-(4-Chloro-2-cyclopropylpyridin-3-yl)-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]hexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxamide

Reagents, catalysts & solvents 2

HCID 111,2-DichloroethaneSolventHCID 6344DichloromethaneSolvent2×

Procedure

L1 (1.0 eq.) and DIPEA (5.0 eq.) in DCM (0.1M) was slowly added to an ice cooled solution of triphosgene (0.33 eq.) in DCM (0.1M). The reaction mixture was stirred 30 min at RT and slowly added to a solution of Example 4, D2 (0.5 eq) and DIPEA (0.5 eq) in DCE (0.1M). The reaction mixture was stirred 3 h at RT, volatiles were removed under reduced pressure and the crude product was purified by preparative RP-HPLC using H2O (0.1% TFA) and MeCN (0.1% TFA) as eluents. The desired fractions were lyophilized to afford the title compound as a white powder. 1H-NMR (400 MHz, DMSO-d6, 300K) δ 8.80 (1H, br. s), 8.24 (1H, d, J=5.1 Hz), 7.34 (1H, d, J=5.1 Hz), 7.32-7.26 (2H, m), 7.25-7.17 (3H, m), 4.39 (1H, dd, J=4.1 and 13.0 Hz), 4.17-4.06 (2H, m), 3.97-3.90 (1H, m), 3.12-2.88 (3H, m), 2.72-2.65 (1H, m), 2.43-2.35 (1H, m), 2.30-2.20 (1H, m), 1.55-1.47 (1H, m), 1.45-1.38 (1H, m), 0.98-0.90 (4H, m). MS (ES) C24H24ClN5O3 requires: 465, found: 466, 468 (M+H)+.

Workup

  1. stirringThe reaction mixture was stirred 3 h at RT
  2. customvolatiles were removed under reduced pressure
  3. customthe crude product was purified by preparative RP-HPLC

Sources & evidence

ORD record
ord-016a66526bb04d488627c90309045fc1
Source dataset
uspto-grants-2013_06
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08470823B2

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes